Malin eyes more investments and returning cash in 2022
Litigation-related costs came to €400,000 last year as founders sue for direct stake
Litigation-related costs came to €400,000 last year as founders sue for direct stake
Apple soared and Zoom slumped in a year that saw markets surge to record levels
Uniphar’s gross profit surges 31% in the first half of the year
Irish biopharmaceutical company stake part of package sold to Rosetta Capital
ISIF owns almost 11% of Malin, which saw the value of its portfolio jump since late 2019
Cantillon: Davy says Malin shareholders can expect to see payout of close to €50m based on Monday’s share price
Irish life sciences company holds 10% stake in immunotherapy firm
Troubled asset manager thought to have sold 1.6m shares earlier this week
Biopharmaceutical company Kymab identified as one of Malin’s four ‘core assets’
Former Ardagh CEO Ian Curley to become executive chairman on an interim basis
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices